4-[[3,5-dihydroxy-6-(hydroxymethyl)-4-methyloxan-2-yl]methyl]-2,3,5,6-tetrahydroxy-N-[3-[methyl-[4-[(3R,10S,12S,13R)-3,7,12-trihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoyl]amino]propyl]hexanamide

C42H74N2O13 — CID 91037841

IUPAC4-[[3,5-dihydroxy-6-(hydroxymethyl)-4-methyloxan-2-yl]methyl]-2,3,5,6-tetrahydroxy-N-[3-[methyl-[4-[(3R,10S,12S,13R)-3,7,12-trihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoyl]amino]propyl]hexanamide
SMILESCC(CCC(=O)N(C)CCCNC(=O)C(O)C(O)C(CC1OC(CO)C(O)C(C)C1O)C(O)CO)C1CCC2C3C(O)CC4C[C@H](O)CC[C@]4(C)C3C[C@H](O)[C@]12C
InChIInChI=1S/C42H74N2O13/c1-21(26-8-9-27-35-28(18-33(50)42(26,27)4)41(3)12-11-24(47)15-23(41)16-29(35)48)7-10-34(51)44(5)14-6-13-43-40(56)39(55)38(54)25(30(49)19-45)17-31-36(52)22(2)37(53)32(20-46)57-31/h21-33,35-39,45-50,52-55H,6-20H2,1-5H3,(H,43,56)/t21?,22?,23?,24-,25?,26?,27?,28?,29?,30?,31?,32?,33+,35?,36?,37?,38?,39?,41+,42-/m1/s1
InChIKeyPAGYYOBOLCPHCC-VNBWBCEESA-N
MW815.05 g/mol
LogP-0.47
Rot. Bonds16

About 4-[[3,5-dihydroxy-6-(hydroxymethyl)-4-methyloxan-2-yl]methyl]-2,3,5,6-tetrahydroxy-N-[3-[methyl-[4-[(3R,10S,12S,13R)-3,7,12-trihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoyl]amino]propyl]hexanamide

4-[[3,5-dihydroxy-6-(hydroxymethyl)-4-methyloxan-2-yl]methyl]-2,3,5,6-tetrahydroxy-N-[3-[methyl-[4-[(3R,10S,12S,13R)-3,7,12-trihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoyl]amino]propyl]hexanamide (PubChem CID 91037841) has the molecular formula C42H74N2O13 and a molecular weight of 815.05 g/mol. Its IUPAC name is 4-[[3,5-dihydroxy-6-(hydroxymethyl)-4-methyloxan-2-yl]methyl]-2,3,5,6-tetrahydroxy-N-[3-[methyl-[4-[(3R,10S,12S,13R)-3,7,12-trihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoyl]amino]propyl]hexanamide.

Molecular Properties

Compound Name4-[[3,5-dihydroxy-6-(hydroxymethyl)-4-methyloxan-2-yl]methyl]-2,3,5,6-tetrahydroxy-N-[3-[methyl-[4-[(3R,10S,12S,13R)-3,7,12-trihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoyl]amino]propyl]hexanamide
PubChem CID91037841
Molecular FormulaC42H74N2O13
Molecular Weight815.05 g/mol
Exact Mass814.52
IUPAC Name4-[[3,5-dihydroxy-6-(hydroxymethyl)-4-methyloxan-2-yl]methyl]-2,3,5,6-tetrahydroxy-N-[3-[methyl-[4-[(3R,10S,12S,13R)-3,7,12-trihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoyl]amino]propyl]hexanamide
SMILESCC(CCC(=O)N(C)CCCNC(=O)C(O)C(O)C(CC1OC(CO)C(O)C(C)C1O)C(O)CO)C1CCC2C3C(O)CC4C[C@H](O)CC[C@]4(C)C3C[C@H](O)[C@]12C
InChIInChI=1S/C42H74N2O13/c1-21(26-8-9-27-35-28(18-33(50)42(26,27)4)41(3)12-11-24(47)15-23(41)16-29(35)48)7-10-34(51)44(5)14-6-13-43-40(56)39(55)38(54)25(30(49)19-45)17-31-36(52)22(2)37(53)32(20-46)57-31/h21-33,35-39,45-50,52-55H,6-20H2,1-5H3,(H,43,56)/t21?,22?,23?,24-,25?,26?,27?,28?,29?,30?,31?,32?,33+,35?,36?,37?,38?,39?,41+,42-/m1/s1
InChIKeyPAGYYOBOLCPHCC-VNBWBCEESA-N
XLogP-0.47
TPSA260.94 Ų
H-Bond Donors11
H-Bond Acceptors13
Rotatable Bonds16
Heavy Atoms57
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 500815.05
LogP ≤ 5-0.47
H-Bond Donors ≤ 511
H-Bond Acceptors ≤ 1013

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}

Analyze 4-[[3,5-dihydroxy-6-(hydroxymethyl)-4-methyloxan-2-yl]methyl]-2,3,5,6-tetrahydroxy-N-[3-[methyl-[4-[(3R,10S,12S,13R)-3,7,12-trihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoyl]amino]propyl]hexanamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 4-[[3,5-dihydroxy-6-(hydroxymethyl)-4-methyloxan-2-yl]methyl]-2,3,5,6-tetrahydroxy-N-[3-[methyl-[4-[(3R,10S,12S,13R)-3,7,12-trihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoyl]amino]propyl]hexanamide?
The IUPAC name of 4-[[3,5-dihydroxy-6-(hydroxymethyl)-4-methyloxan-2-yl]methyl]-2,3,5,6-tetrahydroxy-N-[3-[methyl-[4-[(3R,10S,12S,13R)-3,7,12-trihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoyl]amino]propyl]hexanamide (CID 91037841) is 4-[[3,5-dihydroxy-6-(hydroxymethyl)-4-methyloxan-2-yl]methyl]-2,3,5,6-tetrahydroxy-N-[3-[methyl-[4-[(3R,10S,12S,13R)-3,7,12-trihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoyl]amino]propyl]hexanamide.
What is the SMILES notation for 4-[[3,5-dihydroxy-6-(hydroxymethyl)-4-methyloxan-2-yl]methyl]-2,3,5,6-tetrahydroxy-N-[3-[methyl-[4-[(3R,10S,12S,13R)-3,7,12-trihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoyl]amino]propyl]hexanamide?
The canonical SMILES for 4-[[3,5-dihydroxy-6-(hydroxymethyl)-4-methyloxan-2-yl]methyl]-2,3,5,6-tetrahydroxy-N-[3-[methyl-[4-[(3R,10S,12S,13R)-3,7,12-trihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoyl]amino]propyl]hexanamide is CC(CCC(=O)N(C)CCCNC(=O)C(O)C(O)C(CC1OC(CO)C(O)C(C)C1O)C(O)CO)C1CCC2C3C(O)CC4C[C@H](O)CC[C@]4(C)C3C[C@H](O)[C@]12C.
What is the InChIKey of 4-[[3,5-dihydroxy-6-(hydroxymethyl)-4-methyloxan-2-yl]methyl]-2,3,5,6-tetrahydroxy-N-[3-[methyl-[4-[(3R,10S,12S,13R)-3,7,12-trihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoyl]amino]propyl]hexanamide?
The InChIKey is PAGYYOBOLCPHCC-VNBWBCEESA-N. The full InChI is InChI=1S/C42H74N2O13/c1-21(26-8-9-27-35-28(18-33(50)42(26,27)4)41(3)12-11-24(47)15-23(41)16-29(35)48)7-10-34(51)44(5)14-6-13-43-40(56)39(55)38(54)25(30(49)19-45)17-31-36(52)22(2)37(53)32(20-46)57-31/h21-33,35-39,45-50,52-55H,6-20H2,1-5H3,(H,43,56)/t21?,22?,23?,24-,25?,26?,27?,28?,29?,30?,31?,32?,33+,35?,36?,37?,38?,39?,41+,42-/m1/s1.
What are the key properties of 4-[[3,5-dihydroxy-6-(hydroxymethyl)-4-methyloxan-2-yl]methyl]-2,3,5,6-tetrahydroxy-N-[3-[methyl-[4-[(3R,10S,12S,13R)-3,7,12-trihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoyl]amino]propyl]hexanamide?
4-[[3,5-dihydroxy-6-(hydroxymethyl)-4-methyloxan-2-yl]methyl]-2,3,5,6-tetrahydroxy-N-[3-[methyl-[4-[(3R,10S,12S,13R)-3,7,12-trihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoyl]amino]propyl]hexanamide has a molecular weight of 815.05 g/mol, XLogP of -0.47, 16 rotatable bonds, 11 hydrogen bond donors, and 13 hydrogen bond acceptors.
Where does this data come from?
All data for 4-[[3,5-dihydroxy-6-(hydroxymethyl)-4-methyloxan-2-yl]methyl]-2,3,5,6-tetrahydroxy-N-[3-[methyl-[4-[(3R,10S,12S,13R)-3,7,12-trihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoyl]amino]propyl]hexanamide is sourced from PubChem (CID 91037841), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).